Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Niacin and Resveratrol are closely matched across evidence, studies, and safety.
Verdict
Probably helps
8 of 15 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
9 of 11 studies with measurable effects showed benefit.
Top outcomes
500-2000mg daily for lipid effects; 50-500mg for general health
With food (reduces flush), Evening for lipid effects, Split doses for high amounts
Immediate-release niacin (nicotinic acid)
150-500mg trans-resveratrol
With a meal containing fat
Trans-resveratrol capsules
4-8 weeks
4-8 weeks
30-60 minutes after dose
4-12 weeks
4-8 weeks
Niacin for primary and secondary prevention of cardiovascular events
The Cochrane database of systematic reviews (2017) · Meta analysis · n=39195
Participants randomised to niacin were more likely to discontinue treatment due to side effects than participants randomised to control group (RR 2.17, 95% CI 1.70 to 2.77; participants = 33,539; studies = 17; I2 = 77%; moderate-quality evidence).
Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials
Atherosclerosis (2025) · Meta analysis · n=145314
Among available LLTs, PCSK9mAbs, inclisiran, CETPi, and niacin significantly decreased Lp(a) levels.
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Nature medicine (2024) · Meta analysis
Lastly, treatment with physiological levels of 4PY, but not its structural isomer 2PY, induced expression of VCAM-1 and leukocyte adherence to vascular endothelium in mice.
A Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Impact of Resveratrol Supplementation on Anthropometric Indices in Patients With Type 2 Diabetes
Phytotherapy research : PTR (2025) · Meta analysis · n=614
We determined overall effect sizes using a random-effects model and assessed heterogeneity using the I 2 statistic and Cochrane's Q test.
Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities
International journal of molecular sciences (2024) · Systematic review · n=200
Over the last 20 years, there have been almost 200 studies evaluating resveratrol across at least 24 indications, including cancer, menopause symptoms, diabetes, metabolic syndrome, and cardiovascular disease.
Resveratrol and Female Fertility: A Systematic Review
International journal of molecular sciences (2024) · Systematic review
The current literature, though limited, suggests that resveratrol may play a role in female infertility.
Based on multiple meta-analyses showing HDL increases. Higher doses increase discontinuation rates due to side effects (RR 2.17). Immediate-release forms have better lipid effects but more flushing.
Based on meta-analysis showing TNF-α reduction in young and obese subjects. Effect sizes were modest and heterogeneity was high (I2=60-74%). Higher doses associated with increased GI upset risk.
AI-estimated from published studies. Interpret as directional guidance.
Both Niacin and Resveratrol are closely matched — the best choice depends on your specific health goals.
For reduce inflammation, Niacin has a higher relevance score (85 vs 65).
No known interactions between Niacin and Resveratrol have been documented in our database. However, always consult a healthcare provider before combining supplements.